ATE471338T1 - Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen - Google Patents

Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen

Info

Publication number
ATE471338T1
ATE471338T1 AT06831859T AT06831859T ATE471338T1 AT E471338 T1 ATE471338 T1 AT E471338T1 AT 06831859 T AT06831859 T AT 06831859T AT 06831859 T AT06831859 T AT 06831859T AT E471338 T1 ATE471338 T1 AT E471338T1
Authority
AT
Austria
Prior art keywords
hynic
interleukin
site
inflammations
hydrazine
Prior art date
Application number
AT06831859T
Other languages
English (en)
Inventor
Huub Rennen
Otto Boerman
Original Assignee
Stichting Katholieke Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Katholieke Univ filed Critical Stichting Katholieke Univ
Application granted granted Critical
Publication of ATE471338T1 publication Critical patent/ATE471338T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06831859T 2005-10-14 2006-10-13 Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen ATE471338T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05077365 2005-10-14
PCT/IB2006/003899 WO2007042946A2 (en) 2005-10-14 2006-10-13 Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (hynic) moieties and its use in diagnosis of infection and inflammation

Publications (1)

Publication Number Publication Date
ATE471338T1 true ATE471338T1 (de) 2010-07-15

Family

ID=37943188

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06831859T ATE471338T1 (de) 2005-10-14 2006-10-13 Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen

Country Status (13)

Country Link
US (1) US20080233084A1 (de)
EP (1) EP1934251B1 (de)
JP (1) JP2009511565A (de)
CN (1) CN101296941A (de)
AT (1) ATE471338T1 (de)
AU (1) AU2006300823A1 (de)
BR (1) BRPI0617195A2 (de)
CA (1) CA2625993A1 (de)
DE (1) DE602006014980D1 (de)
IL (1) IL190581A0 (de)
RU (1) RU2008114208A (de)
WO (1) WO2007042946A2 (de)
ZA (1) ZA200801921B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251364B1 (en) * 1999-03-29 2001-06-26 Dupont Pharmaceuticals Company Ternary ligand complexes useful as radiopharmaceuticals
US6726895B2 (en) * 2001-04-03 2004-04-27 Board Of Trustees Of The Leland Stanford Junior University Method of imaging cell death in vivo
EP1283216A1 (de) * 2001-08-10 2003-02-12 Mallinckrodt Inc. Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung

Also Published As

Publication number Publication date
US20080233084A1 (en) 2008-09-25
EP1934251A2 (de) 2008-06-25
CA2625993A1 (en) 2007-04-19
JP2009511565A (ja) 2009-03-19
AU2006300823A1 (en) 2007-04-19
CN101296941A (zh) 2008-10-29
BRPI0617195A2 (pt) 2011-07-19
DE602006014980D1 (de) 2010-07-29
WO2007042946A3 (en) 2007-10-04
ZA200801921B (en) 2010-09-29
RU2008114208A (ru) 2009-11-20
IL190581A0 (en) 2008-11-03
WO2007042946A2 (en) 2007-04-19
EP1934251B1 (de) 2010-06-16

Similar Documents

Publication Publication Date Title
DK1571970T3 (da) Diagnose og monitorering af sygdomme
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
WO2008030973A3 (en) Methods and compositions for the detection of protein folding disorders
MA29836B1 (fr) Proteines de fusion avec l'albumine
MY148086A (en) Antibodies directed against amyloid-beta peptide and methods using same
NO20072721L (no) Polypeptides that bind BR3 and uses thereof
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
HRP20140888T1 (hr) Humana monoklonalna protutijela za humani il-4
DE60308915D1 (de) Kombination aus beta-2-adrenozeptor-agonisten und aminozuckern und ihre verwendung zur behandlung von immunmodulatorischen erkrankungen
TW200617174A (en) Method of diagnosing lawsonia intracellularis
WO2008127680A3 (en) Diagnosis and treatment of diseases caused by misfolded proteins
RS53083B (en) RECOMBINANT ELASTASIS PROTEINS AND THE METHODS OF PRODUCTION AND USE OF THE SAME
WO2007074456A3 (en) Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids
ATE551357T1 (de) Markerpeptid für die alzheimer-krankheit
ATE471338T1 (de) Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen
DE602005023712D1 (de) Modifizierte allergene der ns-ltps-familie enthaltende fusionsproteine, deren verwendung und pharmazeutische zusammensetzung, die diese verbindungen enthält
EP2423225A3 (de) NOGO-A-bindende Moleküle und deren pharmazeutische Verwendung
WO2007039699A3 (fr) Substrat proteique pour la detection de l'activite calpaine 3
ATE447021T1 (de) Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen
ITRM20050045A1 (it) Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi.
NO20081503L (no) T-celle adhesjonsmolekyl, og antistoff dertil
ATE511643T1 (de) Fragment des neurosekretorischen proteins vgf als biomarker für morbus alzheimer
AR062117A1 (es) Composicion y metodo para el tratamiento de tumores
WO2008040882A3 (fr) Méthode de diagnostic de maladies neuropsychiatriques, de troubles du comportement alimentaire ou de maladies métaboliques

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties